Pfizer Fellowships
Pfizer Research & Development Groton, CT
Pfizer Inc., in conjunction with MCPHS, offers a unique two-year post-PharmD fellowship program in Global Clinical Supply (GCS) with a focus on Clinical Research Pharmacy.
Fellowship Overview
This two-year fellowship program provides a comprehensive post-doctoral experience that fosters professional growth and develops the necessary skills for a successful career in Research and Development in the biopharmaceutical industry. During their first year, fellows will receive in-depth training in each of the following GCS disciplines and participate in rotational modules throughout other areas within the drug development process:
- Clinical Research Pharmacy
- Clinical Supply Information Systems
- Clinical Supply Operations
- Clinical Supply Strategy and Management
- Quality Assurance
In their second year, fellows will focus on projects within Clinical Research Pharmacy. Throughout the fellowship, the Global Clinical Supply fellows will be integral members of Pfizer’s Global Clinical Supply organization. The fellows will have the opportunity to gain valuable experience in key functional areas that set and operationalize the clinical supply strategy, systems, packaging/labeling, logistics, as well as provide instructions and training of investigational products (IP) in compliance with Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) standards.
About Pfizer
For 175 years, Pfizer has delivered breakthrough medicines that change patients’ lives. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of global medicines in Oncology, Vaccines, Anti-Infectives, Inflammation and Immunology, as well as Internal Medicine and Hospital.
Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatment, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world.
Please see our brochure for additional details.